JAMA editor says she was misled again

Share this article:
Just days after an announced crackdown on researchers who fail to disclose their ties to drug makers, the editor of the Journal of the American Medical Association (JAMA) said she has been misled again, this time by the authors of a study linking severe migraines to heart attacks in women. All six of the study’s authors have done consulting work or received research financing from makers of treatments for migraines or heart-related problems but did not report their financial ties because they did not believe they were relevant to the study. Their research appears in JAMA’s latest edition. JAMA editor Catherine DeAngelis told the Associated Press she would have published the authors’ associations with drug makers had she known about them. JAMA on Tuesday posted a letter on its Web site explaining the omissions, DeAngelis’ response and issuing a correction. Last week, JAMA disclosed that authors of a depression study appearing in its pages failed to reveal ties to makers of antidepressants. Two months ago, JAMA reported similar omissions from authors of a study linking certain arthritis drugs to cancer.
Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Media

Five things for pharma marketers to know: Wednesday, October 22

Five things for pharma marketers to know: ...

Novo partners with YouTube star for diabetes vids; hedge fund wants Amgen to split up; J&J ramps up Ebola vaccine production.

Mucinex gets a revamp

Mucinex gets a revamp

After 10 years of "Mucinex In. Mucus Out," the congestion-relief treatment gets a new look from Reckitt Beckinser's recently appointed AOR McCann New York.

Mixed reaction to a health-centric Facebook feature

Mixed reaction to a health-centric Facebook feature

The ACLU is among those questioning the positives of the rumored healthcare effort.